搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Anaeromyxobacter dehalogenans 30S ribosomal protein S20 (rpsT) CSB-YP493768BYS
CSB-EP493768BYS
CSB-BP493768BYS
CSB-MP493768BYS
CSB-EP493768BYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans Tyrosine--tRNA ligase (tyrS) CSB-YP493769BYS
CSB-EP493769BYS
CSB-BP493769BYS
CSB-MP493769BYS
CSB-EP493769BYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase (lpxA) CSB-YP493770BYS
CSB-EP493770BYS
CSB-BP493770BYS
CSB-MP493770BYS
CSB-EP493770BYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP493771BYS
CSB-EP493771BYS
CSB-BP493771BYS
CSB-MP493771BYS
CSB-EP493771BYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans Maf-like protein A2cp1_1450 (A2cp1_1450) CSB-YP493772BYS
CSB-EP493772BYS
CSB-BP493772BYS
CSB-MP493772BYS
CSB-EP493772BYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Picea sitchensis Anamorsin homolog 1 CSB-YP493773EVO
CSB-EP493773EVO
CSB-BP493773EVO
CSB-MP493773EVO
CSB-EP493773EVO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Talaromyces stipitatus Mitochondrial distribution and morphology protein 10 (mdm10) CSB-YP493774TKZ
CSB-EP493774TKZ
CSB-BP493774TKZ
CSB-MP493774TKZ
CSB-EP493774TKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Talaromyces stipitatus Amino-acid acetyltransferase, mitochondrial (arg2), partial CSB-YP493775TKZ
CSB-EP493775TKZ
CSB-BP493775TKZ
CSB-MP493775TKZ
CSB-EP493775TKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Talaromyces stipitatus Altered inheritance of mitochondria protein 24, mitochondrial (aim24) CSB-YP493776TKZ
CSB-EP493776TKZ
CSB-BP493776TKZ
CSB-MP493776TKZ
CSB-EP493776TKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Talaromyces stipitatus Maintenance of mitochondrial morphology protein 1 (mmm1), partial CSB-YP493777TKZ
CSB-EP493777TKZ
CSB-BP493777TKZ
CSB-MP493777TKZ
CSB-EP493777TKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus flavus Probable endo-beta-1,4-glucanase D (eglD) CSB-YP493778DOX
CSB-EP493778DOX
CSB-BP493778DOX
CSB-MP493778DOX
CSB-EP493778DOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus flavus Probable exopolygalacturonase C (pgxC) CSB-YP493779DOX
CSB-EP493779DOX
CSB-BP493779DOX
CSB-MP493779DOX
CSB-EP493779DOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus flavus Probable glucan 1,3-beta-glucosidase A (exgA) CSB-YP493780DOX
CSB-EP493780DOX
CSB-BP493780DOX
CSB-MP493780DOX
CSB-EP493780DOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus flavus Probable mannosyl-oligosaccharide alpha-1,2-mannosidase 1B (mns1B) CSB-YP493781DOX
CSB-EP493781DOX
CSB-BP493781DOX
CSB-MP493781DOX
CSB-EP493781DOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus flavus Pentafunctional AROM polypeptide (aroM), partial CSB-YP493782DOX
CSB-EP493782DOX
CSB-BP493782DOX
CSB-MP493782DOX
CSB-EP493782DOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus flavus Probable E3 ubiquitin-protein ligase hulA (hulA), partial CSB-YP493783DOX
CSB-EP493783DOX
CSB-BP493783DOX
CSB-MP493783DOX
CSB-EP493783DOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus flavus Probable arabinan endo-1,5-alpha-L-arabinosidase B (abnB) CSB-YP493784DOX
CSB-EP493784DOX
CSB-BP493784DOX
CSB-MP493784DOX
CSB-EP493784DOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus flavus Tethering factor for nuclear proteasome sts1 (sts1) CSB-YP493785DOX
CSB-EP493785DOX
CSB-BP493785DOX
CSB-MP493785DOX
CSB-EP493785DOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus flavus Probable Xaa-Pro aminopeptidase pepP (pepP) CSB-YP493786DOX
CSB-EP493786DOX
CSB-BP493786DOX
CSB-MP493786DOX
CSB-EP493786DOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus flavus Probable arabinan endo-1,5-alpha-L-arabinosidase A (abnA) CSB-YP493787DOX
CSB-EP493787DOX
CSB-BP493787DOX
CSB-MP493787DOX
CSB-EP493787DOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>